[1]
|
Ogden, C., Carroll, M., Curtin, L., McDowel, M. and Flegal, K. (2006) Prevalence of overweight and obesity in the United States, 1999-2008. JAMA: Journal of the American Medical Association, 295, 1549-1555.
doi:10.1001/jama.295.13.1549
|
[2]
|
CDC. (2010) Vital signs: State-specific prevalence of obesity among adults—United States, 2009. Morbidity and Mortality Weekly Report, 59, 1-5.
|
[3]
|
Finkelstein, E., Fiebelkorn, I. and Wang, G. (2004) State-level estimates of annual medical expenditures attributable to obesity. Obesity Research, 1, 18-24.
doi:10.1038/oby.2004.4
|
[4]
|
Dixon, J., Dixon, M. and O’Brien, P. (2003) Depression in association with severe obesity: Changes with weight loss. Archives of Internal Medicine, 163, 2058-2065.
doi:10.1001/archinte.163.17.2058
|
[5]
|
Resnick, H. V. (2000) Relation of weight gain and weight loss on subsequent diabetes risk in overweight adults. Journal of Epidemiology and Community Health, 54, 596-602. doi:10.1136/jech.54.8.596
|
[6]
|
Ford, E., Williamson, D. and Liu, S. (1997) Weigh changes and diabetes incidence: Findings from a national cohort of US adults. American Journal of Epidemiology, 146, 214-222.
|
[7]
|
Wilson, P., D’Agostino, R., Sullivan, L., Parise, H. and Kannel, W. (2002) Overweight and obesity as determinants of cardiovascular risk: The Framingham experience. Archives of Internal Medicine, 162, 1867-1872.
doi:10.1001/archinte.162.16.1867
|
[8]
|
CDC. (2011) National diabetes fact sheet: National estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention
|
[9]
|
CDC. (2004) Prevalence of overweight and obesity among adults with diagnosed diabetes—United States, 1988-1994 and 1999-2002. Morbidity and Mortality Weekly Report, 53, 1066-1068.
|
[10]
|
Ripsin, C., Kang, H. and Urban, R. (2009) Management of blood glucose in type 2 diabetes mellitus. American Family Physician, 79, 29-36.
|
[11]
|
Nathan, D., Buse, J., Davidson, M., Heine, R., Holman, R., Sherwin, R., et al. (2009) Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care, 32, 193-203. doi:10.2337/dc08-9025
|
[12]
|
American Diabetes Association. (2008) Economic costs of diabetes in the U.S. in 2007. Diabetes Care, 31, 596-615.
|
[13]
|
Meigs, J., Singer, D., Sulivan, L.M., D. K. and D’Agostino, R. (1997) Metabolic control and prevalent cardiovascular disease in non-insulin dependent diabetes mellitus: The NIDDM Patient Outcome Research Team. American Journal of Medicine, 102, 38-47.
doi:10.1016/S0002-9343(96)00383-X
|
[14]
|
Wong, T., Klein, R. and Islam, F.E. (2006) Diabetic retinopathy in a multi-ethnic cohort in the United States. American Journal of Ophthalmology, 141, 446.
doi:10.1016/j.ajo.2005.08.063
|
[15]
|
Lloyd, C., Kuller, L., Ellis, D., Becker, D., Wing, R. and Orchard, T. (1996) Coronary artery disease in IDDM: gender differences in risk factors but not risk. Arteriosclerosis, Thrombosis and Vascular Biology, 16, 720-726.
doi:10.1161/01.ATV.16.6.720
|
[16]
|
Tesfaye, S., Chaturvedi, N., Eaton, S., Ward, J., Manes, C., Ionescu-Tirgoviste, C., et al. (2005) Vascular risk factors for diabetic neuropathy. New England Journal of Medicine, 352, 341-350. doi:10.1056/NEJMoa032782
|
[17]
|
Klein, R., Klein, B.E., Moss, S.E. and Cruickshanks, K.J. (1994) Relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy. Archives of Internal Medicine, 154, 2169-2178.
doi:10.1001/archinte.154.19.2169
|
[18]
|
Anderson, J., Conley, S. and Nicholas, A. (2007) One hundred pound weight losses with an intensive behavioral program: Changes in risk factors in 118 patients with long-term follow-up. American Journal of Clinical Nutrition, 86, 301-307.
|
[19]
|
Furlow, E. and Anderson, J. (2009) A systematic review of targeted outcomes associated with a medically supervised commercial weight loss program. American Dietetic Association, 109, 1417-1421.
doi:10.1016/j.jada.2009.05.003
|
[20]
|
NIH National Heart Lung and Blood Institute. (1998) Clinical guidelines on the identification, evaluation and treatment of overweight and obesity in adults: The evidence report. Obesity Research, 6, 51S-209S.
|
[21]
|
The Look AHEAD Research Group. (2010) Long-term effects of a lifestyle intervention on weight and cardiovascular risk Factors in individuals with type 2 diabetes mellitus: Four-year results of the Look AHEAD Trial. Archives of Internal Medicine, 170, 1566-1576.
doi:10.1001/archinternmed.2010.334
|
[22]
|
The Look AHEAD Research Group. (2007) Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes. Diabetes Care, 30, 1374-1384. doi:10.2337/dc07-0048
|
[23]
|
Anderson, J., Grant, L. G. and Stifler, L. (2007) Weight loss and long term follow up in individuals treated with an intense behavioral program. International Journal of Obesity, 31, 488-493. doi:10.1038/sj.ijo.0803541
|
[24]
|
Agurs-Collins, T., Kumanyika, S. and Ten Have, T.A.-C. (1997) A randomized controlled trial of weight reduction and exercise for diabetes management in older African-American subjects. Diabetes Care, 20, 1503-1511.
doi:10.2337/diacare.20.10.1503
|
[25]
|
Albu, J., Heilronn, L., Kelley, D. and Smith, S. (2010) Metabolic changes following a 1-year diet and exercise intervention in patients with type 2 diabetes. Diabetes, 59, 627-633. doi:10.2337/db09-1239
|
[26]
|
Kelley, D., Kuller, L.M., Harper, P., Mancino, J. and Kalhan, S. (2004) Effects of moderate weight loss and orlistat on insulin resistance, regional adiposity, and fatty acids in type 2 diabetes. Diabetes Care, 27, 33-40.
doi:10.2337/diacare.27.1.33
|
[27]
|
Diabetes Prevention Program Research Group. (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine, 346, 393-403. doi:10.1056/NEJMoa012512
|
[28]
|
American Diabetes Association. (2010) Standards of medical care in diabetes-2010. Diabetes Care, 33, S11-S61.
doi:10.2337/dc10-S011
|
[29]
|
Stratton, I., Adler, A., Neil, A., Matthew, D., Manley, S., Cull, C., et al. (2000) Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS35): Prospective observational study. British Medical Journal, 321, 405-412.
doi:10.1136/bmj.321.7258.405
|
[30]
|
Gaede, P., Lund-Andersen, H., Parving, H.-H. and Pedersen, O. (2008) Effect of a multifactorial intervention on mortality in type 2 diabetes. New England Journal of Medicine, 358, 580-591. doi:10.1056/NEJMoa0706245
|
[31]
|
DeFronzo, R., Goodman, A. and Group, M. M. (1995) Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. New England Journal of Medicine, 333, 541-549. doi:10.1056/NEJM199508313330902
|
[32]
|
Schauer, P., Burguera, B., Ikramuddin, S., Cottam, D., Gourash, W., Hamad, G., et al. (2003). Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Annals of Surgery, 238, 467-484.
|
[33]
|
Wing, R., Koeske, R., Epstein, L., Norwalk, M., Gooding, W. and Becker, D. (1987). Long-term effects of modest weight loss in type II diabetic patients. Achives of Internal Medicine, 147, 1749-1753.
doi:10.1001/archinte.147.10.1749
|
[34]
|
Redmon, B.J., Reck, K., Raatz, S., Swanson, J., Kwong, C., Ji, H., et al. (2005) Two year outcome of a combination of weight loss therapies for type 2 diabetes. Diabetes Care, 28, 1311-1315. doi:10.2337/diacare.28.6.1311
|